stars 1 stars 2 stars 3

PeploBio is a specialist CRO supporting pharmaceutical, biotech, and diagnostic partners in the development and clinical validation of biomarker-driven assays. We combine scientific depth with operational agility to translate complex biology into clinically validated tools. Our expertise spans immune monitoring, advanced biomarker analysis, assay development, and regulatory support — with a strong track record delivering studies across FDA, IVDR, and UKCA frameworks. Our Services: - Biomarker Analysis & Translational Research - Advanced profiling of protein and molecular biomarkers to support clinical development and mechanistic insight - Immune Monitoring - Custom flow cytometry and Mass Spec services - Assay Development & Validation - Design, optimisation, and validation of assays across RUO, LDT, and regulatory pathways - Regulatory Strategy & Clinical Studies - Design and execution of analytical and clinical performance studies aligned with IVDR, FDA, and UKCA requirements Why PeploBio? - Trusted partner to translational medicine teams, biotech innovators, and diagnostic manufacturers - Expertise spanning early discovery through to late-stage clinical validation - Biomarker and assay platform expertise across immunology, metabolic disease, and complex biology - Agile team with global reach: London (UK), Cyprus (EU), and North Carolina (US)

PeploBio Questions

Mohammed Rashad is the COO of PeploBio.

2 people are employed at PeploBio.

Top PeploBio Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users